Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Post-exposure prophylaxis for hepatitis B: active or passive?

S Iwarson1

  • 1Department of Infectious Diseases, Ostra Hospital, University of Göteborg, Sweden.

Lancet (London, England)
|July 15, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Subtypes of Hepatitis B Antigen in Blood Donors and Post-transfusion Hepatitis: Clinical and Epidemiological Aspects.

British medical journal·2010
Same author

Hepatitis A booster vaccination: is there a need?

Lancet (London, England)·2003
Same author

[Exciting progress in the field of infection medicine. Several breakthroughs are to be expected during the next decade].

Lakartidningen·1999
Same author

[New and re-emergent epidemics in the changing surrounding world].

Lakartidningen·1999
Same author

Studies on a Hib-tetanus toxoid conjugate vaccine: effects of co-administered tetanus toxoid vaccine, of administration route and of combined administration with an inactivated polio vaccine.

Vaccine·1999
Same author

[Electronic version of the Fass is also considered to be reliable].

Lakartidningen·1999
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
See all related articles

Passive immunisation with hepatitis B (HB) immune globulin is common post-exposure. Accelerated vaccination offers faster protection, potentially reducing the need for passive immunisation strategies.

Area of Science:

  • Immunology
  • Virology
  • Vaccinology

Background:

  • Hepatitis B (HB) virus infection poses significant public health challenges.
  • Passive immunisation using HB immune globulin is a standard post-exposure prophylaxis.
  • Conventional vaccination regimens induce active immunity against HB virus.

Purpose of the Study:

  • To evaluate the efficacy of accelerated vaccination compared to passive immunisation for hepatitis B (HB) virus exposure.
  • To determine if faster achievement of protective antibody titres with accelerated vaccination impacts the role of passive immunisation.

Main Methods:

  • Comparative analysis of immunisation strategies.
  • Monitoring of antibody titres following different vaccination and passive immunisation protocols.

Related Experiment Videos

Main Results:

  • Accelerated vaccination regimens achieve protective antibody titres significantly faster than conventional methods.
  • The rapid induction of active immunity may offer an alternative to passive immunisation.

Conclusions:

  • Accelerated hepatitis B (HB) vaccination provides rapid protection.
  • The necessity and role of passive immunisation with HB immune globulin warrant re-evaluation in light of accelerated vaccination efficacy.